|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Virtual Liver Resection and Volumetric Analysis of the Future Liver Remnant using Open Source Image Processing Software显示文摘 | Joost R. Vorst Ronald M. Dam Rogier S. A. Stiphout Maartje A. den Broek Ilona H. Hollander Alfons G. H. Kessels Cornelis H. C. Dejong | 2010 | World Journal of Surgery2010，，10： | 2 |
| 2 | Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: Results of a systematic review显示文摘AIM:To investigate adherence rates in tumor necrosis factor-α (TNF-α)-inhibitors in Crohn's disease (CD) and rheumatoid arthritis (RA) by systematic review of medical literature. METHODS:A structured search of PubMed between 2001 and 2011 was conducted to identify publications that assessed treatment with TNF-α inhibitors providing data about adherence in CD and RA. Therapeutic agents of interest where adalimumab, infliximab and etanercept, since these are most commonly used for both diseases. Studies assessing only drug survival or continuation rates were excluded. Data describing adherence with TNF-α inhibitors were extracted for each selected study. Given the large variation between definitions of measurement of adherence, the definitions as used by the authors where used in our calculations. Data were tabulated and also presented descriptively. Sample size-weighted pooled proportions of patients adherent to therapy and their 95%CI were calculated.To compare adherence between infliximab, adalimumab and etanercept, the adherence rates where graphed alongside two axes. Possible determinants of adherence were extracted from the selected studies and tabulated using the presented OR. RESULTS:Three studies on CD and three on RA were identified, involving a total of 8147 patients (953 CD and 7194 RA). We identified considerable variation in the definitions and methodologies of measuring adherence between studies. The calculated overall sample size-weighted pooled proportion for adherence to TNF-α inhibitors in CD was 70% (95%CI:67%-73%) and 59% in RA (95%CI:58%-60%). In CD the adherence rate for infliximab (72%) was highercompared to adalimumab (55%), with a relative risk of 1.61 (95%CI:1.27-2.03), whereas in RA adherence for adalimumab (67%) was higher compared to both infliximab (48%) and etanercept (59%), with a relative risk of 1.41 (95%CI:1.3-1.52) and 1.13 (95%CI:1.10-1.18) respectively. In comparative studies in RA adherence to infliximab was better than etanercept and etanercept did better than adalimumab. In three studies, the most consistent factor associated with lower adherence was female gender. Results for age, immunomodulator use and prior TNF-α inhibitors use were conflicting. CONCLUSION:One-third of both CD and RA patients treated with TNF-α inhibitors are non-adherent. Female gender was consistently identified as a negative determinant of adherence. | Herma H Fidder Maartje MJ Singendonk Mike van der Have Bas Oldenburg Martijn GH van Oijen | 2013 | World Journal of Gastroenterology2013，19，27： | 2 |
| 3 | Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection显示文摘 | Maartje C. van Rijk MD Omgo E. Nieweg MD PhD Emiel J. T. Rutgers MD PhD FRCS Hester S. A. Oldenburg MD PhD Renato Valdés Olmos MD PhD Cornelis A. Hoefnagel MD PhD Bin B. R. Kroon MD PhD FRCS | 2006 | Annals of Surgical Oncology2006，，4： | 1 |
| 4 | Cecostomy in Children with Defecation Disorders显示文摘 | Hayat M. Mousa MD Maartje M. Van Berg MD Donna A. Caniano MD Mark Hogan MD Carlo Lorenzo MD John Hayes PhD | 2006 | Digestive Diseases and Sciences2006，，1： | 1 |
| 5 | Exact ART:A complete implementation of an ART network显示文摘 | Maartje E J Raijmakers Peter Molenaar C M | 1997 | Neural Networks1997，10，4： | 1 |
| 6 | Measurement and modeling of the high-pressure phasebehavior of the binary system carbon dioxide+1,2-ep-oxycyclohexane显示文摘 | Marcus A Van Schilt Rob M Wering Maartje F Kemmere etal | 2005 | J Chem Eng Data2005，50，6： | 1 |
| 7 | Pulmonary and Blood Stream Infections in Adult Living Donor and Cadaveric Liver Transplant Patients显示文摘 | Fuat H. Saner Steven W. M. Olde Damink Goran Pavlakovic Maartje A. J. van den Broek Peter-Michael Rath Georgios C. Sotiropoulos Arnold Radtke Ali Canbay Andreas Paul Silvio Nadalin Massimo Malagó Christoph E. Broelsch | 2008 | Transplantation2008，，11： | 1 |
| 8 | Fac- tors that in fluence treatment adherence of tuberculosis patients living in Java,Indonesia显示文摘 | Bagoes Widjanarko MicheUe Gompelman Maartje Dijkers | 2009 | Patient Preference and Adherence2009，，3： | 1 |
| 9 | Remodeling of the cardiac sodium channel, connexin 43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy显示文摘 | Maartje Noorman Sara Hakim Elise Kessler Judith Groeneweg Moniek G.P.J. Cox Angeliki Asimaki Harold V.M. van Rijen Leonie van Stuijvenberg Halina Chkourko Marcel A.G. van der Heyden Marc A. Vos Nicolaas de Jonge Jasper J. van der Smagt Dennis Dooijes Arya | 2013 | Heart Rhythm2013，，： | 1 |
| 10 | Recognition and diagnosis of sleep disorders in Parkinson' s disease 显示文摘 | Maartje L Willemijn C Joy L | 2012 | J Neurol2012，259，10： | 1 |
| 11 | Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases显示文摘 | Ronald M. Dam Toine M. Lodewick Maartje A.J. Broek Mechteld C. Jong Jan Willem Greve Rob L.H. Jansen Marc H.A. Bemelmans Ulf P. Neumann Steven W.M. Olde Damink Cornelis H.C. Dejong | 2014 | HPB2014，，6： | 1 |
| 12 | Exact ART: A complete implementation of an ART network显示文摘 | Maartje E J Peter R Molenaar C M | 1997 | Neural Networks1997，10，4： | 1 |
| 13 | In search of ]the good life’ for demented elderly显示文摘 | Maartje Schermer | 2003 | Medicine, Health Care and Philosophy2003，，1： | 1 |
| 14 | Using quality indicators to improve hospital care:a review of the literature显示文摘 | Maartje DV Wilco G Mieneke K | 2009 | Int J Qual Health Care2009，21，2： | 1 |
| 15 | Adescriptive force-baknce model for droplet formation atmicrofluidic Y-Junctions显示文摘 | MAARTJE L J S JOLET D R KARIN G P H S | 2010 | American Institute ofChemical Engineers2010，56，10： | 1 |
| 16 | Microfluidic Y-junctions:A robust emulsification systemwith regard to junction design显示文摘 | MAARTJE L J S KARIN G P H S REMKO M B | 2010 | American Institute ofChemical Engineers2010，56，7： | 1 |
| 17 | Characterization of emulsification at flat microchannel Yjunctions显示文摘 | MAARTJE L J S KARIN G P H S REMKO M B | 2009 | Langmuir2009，25，6： | 1 |
| 18 | Moderate dietary sodium restriction added to an- giotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial 显示文摘 | Maartje C Slagman J | 2011 | British Medical Journal2011，343，8： | 1 |
| 19 | Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment显示文摘 | Maartje A. J.Van Den Broek Steven W. M.Olde Damink Cornelis H. C.Dejong HaukeLang MassimoMalagó RajivJalan Fuat H.Saner | 2008 | Liver International2008，，6： | 1 |
| 20 | Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening: Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study显示文摘 | Moniek G.P.J. Cox Paul A. van der Zwaag Christian van der Werf Jasper J. van der Smagt Maartje Noorman Zahir A. Bhuiyan Ans C.P. Wiesfeld Paul G.A. Volders Irene M. van Langen Douwe E. Atsma Dennis Dooijes Arthur van den Wijngaard Arjan C. Houweling Jan D | 2011 | Circulation2011，，23： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员